Elite.irpass.com is a subdomain of irpass.com, which was created on 2002-01-23,making it 22 years ago. It has several subdomains, such as tylertech.irpass.com tandyleather.irpass.com , among others.
Discover elite.irpass.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
HomePage size: 43.771 KB |
Page Load Time: 0.877408 Seconds |
Website IP Address: 66.111.109.111 |
ACNB Corporation Investor Relations investor.acnb.com |
Wayne Savings Investor Relations investors.waynesavings.com |
Bank of Marin Bancorp - Investor Relations investors.bankofmarin.com |
About Hagerty | Corporate Profile | Hagerty corporate.hagerty.com |
Juniata Valley Bank - Corporate Information - Corporate Profile juniatavalley.q4ir.com |
Banc of California Investor Relations investors.bancofcal.com |
Corporate Governance - Corporate Profile | Wintrust Financial Corporation ir.wintrust.com |
Carter Bank & Trust | Corporate Information - Corporate Profile investors.cbtcares.com |
Corporate Overview - Corporate Profile | First United Corporation investors.mybank.com |
CSS Profile Home – CSS Profile | College Board css.collegeboard.org |
Aware Profile | Trading Profile Assessment aware-profile.daytradingpsychology.com |
Corporate Overview - Corporate Profile | Landmark Bancorp, investor.banklandmark.com |
Corporate Profile https://elite.irpass.com/ |
Press Releases https://elite.irpass.com/press_releases |
Investor Contacts https://elite.irpass.com/investor_contacts |
Events & Presentations https://elite.irpass.com/events_presentations |
SEC filings https://elite.irpass.com/sec_filings |
Governance Documents https://elite.irpass.com/governance_documents |
Email Alert https://elite.irpass.com/email_alerts |
Annual Meeting https://elite.irpass.com/shareholder_meeting |
Press Releases https://elite.irpass.com/Elite-Pharmaceuticals-Enters-into-Strategic-Marketing-Alliance-with-Lannett-For-Generic-Adderall174 |
Elite Pharmaceuticals, Inc. Reports Financial Results for Second ... https://elite.irpass.com/Elite-Pharmaceuticals--Inc--Reports-Financial-Results-for-Second-Quarter-of-Fiscal-Year-2024-ended-September-30--2023-and-Pro |
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide ... https://elite.irpass.com/Elite-Pharmaceuticals--Inc--to-Host-Conference-Call-to-Provide-Corporate-Update-and-Discuss-Third-Quarter-2024-Financial-Resu |
Elite Pharmaceuticals, Inc. Reports Financial Results for Third Quarter ... https://elite.irpass.com/Elite-Pharmaceuticals--Inc--Reports-Financial-Results-for-Third-Quarter-of-Fiscal-Year-2024-ended-December-31--2023-and-Provi |
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide ... https://elite.irpass.com/Elite-Pharmaceuticals--Inc--to-Host-Conference-Call-to-Provide-Corporate-Update-and-Discuss-Fiscal-Year-2023-Financial-Result |
Elite Pharmaceuticals Reports Positive Results from a Pivotal ... https://elite.irpass.com/Elite-Pharmaceuticals-Reports-Positive-Results-from-a-Pivotal-Bioequivalence-Study-8-28-2023 |
Elite Pharmaceuticals Receives FDA Approval for Generic Sabril® https://elite.irpass.com/Elite-Pharmaceuticals-Receives-FDA-Approval-for-Generic-Sabril174--6-29-2022 |
Cache-Control: private,no-cache |
Pragma: no-cache |
Content-Type: text/html |
Expires: Tue, 14 May 2024 07:36:37 GMT |
Server: Microsoft-IIS/10.0 |
Access-Control-Allow-Origin: * |
Set-Cookie: ASPSESSIONIDQWTDRRRQ=ODFODCLAMOFPMCKIPMNHAHAF; secure; path=/;SameSite=None; Secure |
Date: Tue, 14 May 2024 07:37:37 GMT |
Content-Length: 38995 |
charset="utf-8"/ |
content="width=device-width, initial-scale=1" name="viewport"/ |
content="IE=edge" http-equiv="X-UA-Compatible" |
content="https://elite.irpass.com" property="og:url"/ |
content="Corporate Profile" property="og:title"/ |
Ip Country: United States |
Latitude: 37.751 |
Longitude: -97.822 |
ELITE Overview Our Facility Management & Key Employees Our Board Careers PRODUCTS PIPELINE Generic Branded TECHNOLOGY Technology Overview How It Works One Bead System Two Bead System INVESTOR RELATIONS Press Releases Events & Presentations SEC Filings Shareholder Meeting Governance Documents Investor Contacts Email Alerts HOME | CAREERS | CONTACT | NEWS | About Elite Overview Management & Key Employees Our Board Careers Products Pipeline Generic Branded Technology Technology Overview How It Works One Bead System Two Bead System Investor Relations Press Releases Events & Presentations SEC Filings Shareholder Meeting Governance Documents Investor Contacts Email Alerts Investor Relations Press Releases Events & Presentations SEC Filings Shareholder Meeting Governance Documents Investor Contacts Email Alerts Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops niche generic products. Elite specializes in developing and manufacturing oral, controlled-release drug products. Elite owns multiple generic products, some of whichare licensed to Prasco, LLC and TAGI Pharma. Our Strategy includes developing generic versions of controlled-release drug products with high barriers to entry. Elite operates a cGMP and DEA-registered facility for research, development, and manufacturing located in Northvale, NJ. Recent News View all Press Releases Investor PresentationSite Map | Privacy | Terms Of Use Copyright © Elite Pharmaceuticals Inc. | All Rights Reserved. ART ™ : Abuse-Resistant Technology for a safer healthier...
Domain Name: IRPASS.COM Registry Domain ID: 82922943_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2023-12-01T11:09:07Z Creation Date: 2002-01-23T13:51:34Z Registry Expiry Date: 2024-12-01T04:59:59Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS1.SAFESECUREWEB.COM Name Server: NS2.SAFESECUREWEB.COM Name Server: NS3.SAFESECUREWEB.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T22:59:20Z <<<